RAPT Therapeutics (RAPT) Leases (2022 - 2024)
Historic Leases for Therapeutics (RAPT) over the last 3 years, with Q3 2024 value amounting to $3.8 million.
- Therapeutics' Leases fell 3256.35% to $3.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $3.8 million, marking a year-over-year decrease of 3256.35%. This contributed to the annual value of $5.2 million for FY2023, which is 2466.86% down from last year.
- Latest data reveals that Therapeutics reported Leases of $3.8 million as of Q3 2024, which was down 3256.35% from $4.3 million recorded in Q2 2024.
- Therapeutics' 5-year Leases high stood at $6.9 million for Q4 2022, and its period low was $3.8 million during Q3 2024.
- Its 3-year average for Leases is $5.6 million, with a median of $5.8 million in 2022.
- Per our database at Business Quant, Therapeutics' Leases soared by 322.68% in 2023 and then crashed by 3256.35% in 2024.
- Therapeutics' Leases (Quarter) stood at $6.9 million in 2022, then decreased by 24.67% to $5.2 million in 2023, then dropped by 26.84% to $3.8 million in 2024.
- Its Leases was $3.8 million in Q3 2024, compared to $4.3 million in Q2 2024 and $4.8 million in Q1 2024.